Literature DB >> 18522450

Impurities in commercial phytantriol significantly alter its lyotropic liquid-crystalline phase behavior.

Yao-Da Dong1, Aurelia W Dong, Ian Larson, Michael Rappolt, Heinz Amenitsch, Tracey Hanley, Ben J Boyd.   

Abstract

The lyotropic liquid-crystalline phase behavior of phytantriol is receiving increasing interest in the literature as a result of similarities with glyceryl monooleate, despite its very different molecular structure. Some differences in the phase-transition temperature for the bicontinuous cubic to reverse hexagonal phase have been reported in the literature. In this study, we have investigated the influence that the commercial source and hence the purity has on the lyotropic phase behavior of phytantriol. Suppression of the phase-transition temperatures (by up to 15 degrees C for the bicontinuous cubic to reverse hexagonal phase transition) is apparent with lower-purity phytantriol. In addition, the composition boundaries were also found to depend significantly on the source and purity of phytantriol, with the bicontinuous cubic phase + excess water boundary occurring at a water content above that reported previously (i.e., >5% higher). Both the temperature and compositional changes in phase boundaries have significant implications on the use of these materials and highlight the impact that subtle levels of impurities can play in the phase behavior of these types of materials.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18522450     DOI: 10.1021/la8005579

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  2 in total

Review 1.  Lipid-based drug delivery systems in the treatment of wet age-related macular degeneration.

Authors:  Joanne D Du; Wye-Khay Fong; Suzanne Caliph; Ben J Boyd
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

Review 2.  Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy.

Authors:  Chelsea R Thorn; Nicky Thomas; Ben J Boyd; Clive A Prestidge
Journal:  Drug Deliv Transl Res       Date:  2021-03-05       Impact factor: 4.617

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.